Christoph Ebenbichler

Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro

Susanne Kaser, Arthur Kaser, A. Sandhofer et al. · Biochemical and Biophysical Research Communications · 2003 · 458 citations

Inflammation, Cytokine, Resistin Messenger-rna Expression +8

A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans

Harald Esterbauer, Clemens Schneitler, Hannes Oberkofler et al. · Nature Genetics · 2001 · 360 citations

Obesity, Metabolic Syndrome, Genetic Determinant +10

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 286 citations · Full text

Metabolic Syndrome, Type 1, Diabetes Management +9

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 285 citations · Full text

Family Medicine, Metabolic Syndrome, Lipid Disorder +10

Evinacumab in Patients with Refractory Hypercholesterolemia

Robert S. Rosenson, Lesley Burgess, Christoph Ebenbichler et al. · New England Journal of Medicine · 2020 · 283 citations · Full text